Hawthorn Berry 2000 mg Alcohol-Free
Product analysis
Hawthorn Berry 2000 mg Alcohol-Free offers an alcohol-free hawthorn preparation. Heart-related findings are mixed and come from specific extracts, so they do not establish the same benefits from this preparation.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The berry, flower and leaf extracts are identified, but their proportions are missing. There is not enough information to judge their combined form quality confidently.
Ingredient Transparency80
The total amount and plant-part extracts are disclosed. Their proportions are missing, so the exact balance cannot be checked.
Value For Money50
The labeled serving offers moderate value. The serving cost does not establish equivalence to preparations used in clinical research.
Customer Satisfaction83
Customer ratings are positive. Thousands of reviews provide a broad view of customer opinion, without proving effectiveness or safety.
Product Focus73
A single botanical gives the formula a clear heart-oriented purpose. Conflicting findings from specific clinical extracts leave its routine cardiovascular benefit uncertain.
- Format
Liquid - Container
- 1 Fluid Ounce(s)
- Per serving
- $0.84
- Customer rating
- 4.6 · 2,004 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Hawthorn Extract (Crataegus monogyna Jacq. Berry Extract, Crataegus monogyna Jacq. Flower Extract, Crataegus monogyna Jacq. Leaf Extract) | 2000 mg |
How this ingredient is rated
Composition and Label Disclosure79
Marker and Preparation Disclosure
Species Name Disclosure
Composition and Label Disclosure
Commercial Price and Usability50
Commercial Price per Labeled Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
- Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
- A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
- [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
- Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
- [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
- Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
- Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
- Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.